MIT and its spin-off, Commonwealth Fusion Systems, have announced a collaboration to establish a new fusion research and education facility on the MIT campus. This initiative is supported by a recent Series B funding round in which CFS raised more than $1.8 billion, bringing its total capital to over $2 billion. The financing was led by Tiger Global Management and included participation from new investors such as Bill Gates, alongside existing backers like The Engine and Temasek. The funds are designated for the construction and operation of the SPARC tokamak, as well as the development of the ARC commercial fusion power plant. Source: Facebook

The new on-campus facility is intended to house the SPARC device after its initial operations, creating a hub for fusion science and engineering education. SPARC, a compact, high-field tokamak, is currently under construction in Devens, Massachusetts. It leverages high-temperature superconducting magnets to achieve the strong magnetic fields necessary for containing a net-energy-gain plasma in a relatively small volume. The project aims to validate the physics and technology required for commercial fusion energy, building upon decades of research from MIT's Plasma Science and Fusion Center. Source: Facebook

The new on-campus facility is intended to house the SPARC device after its initial operations, creating a hub for fusion science and engineering education.

SPARC is projected to be the first privately funded fusion device to achieve a net energy gain, defined as a plasma energy gain factor, or Q_plasma, greater than one. According to the announcement, simulations predict SPARC will produce between 50 and 100 MW of fusion power. The primary goal is to demonstrate a Q factor of at least 2, with performance potentially reaching as high as 10. The device is scheduled to begin operations and demonstrate net energy gain from fusion by 2025, a critical step toward the design of a commercial power plant. Source: Facebook

This funding round represents one of the largest private investments in fusion energy to date, signaling significant investor confidence in the high-field tokamak approach. The capital infusion allows CFS to accelerate its timeline not only for SPARC but also for its successor, ARC, which is envisioned as a pilot power plant capable of delivering electricity to the grid. The collaboration with MIT ensures that the development of this technology is coupled with training the next generation of fusion scientists and engineers, addressing a critical workforce need for the nascent fusion industry. For more details on private investment trends, see the Fusion Funding Index. Source: Facebook